What is hepatorenal syndrome and how does terlipressin help?

Hepatorenal syndrome (HRS) is a life-threatening form of kidney failure occurring in patients with advanced liver disease and portal hypertension. Splanchnic vasodilation leads to reduced effective blood volume and renal vasoconstriction. Terlipressin constricts splanchnic blood vessels, redirecting blood flow to improve renal perfusion, with the goal of reversing kidney failure.

Why does terlipressin carry a respiratory failure warning?

In the CONFIRM trial, 11% of terlipressin-treated patients developed respiratory failure vs 2% on placebo. Terlipressin increases venous return, which in patients with impaired cardiac function and portal hypertension can precipitate pulmonary edema. Oxygen monitoring and respiratory assessment are required during treatment.

How is terlipressin different from vasopressin?

Terlipressin is a prodrug that is slowly converted to lysine vasopressin, providing a longer duration of action (~6 hours vs ~30 minutes) and allowing intermittent IV bolus dosing every 6 hours rather than continuous infusion. It has relatively greater V1a selectivity.

peptide dosing

Terlipressin Dosing & Reconstitution Guide

Q: What is the recommended dose range for Terlipressin?

The research dose range is HRS-1: 0.85 mg IV every 6 hours; may increase to 1.7 mg every 6 hours if serum creatinine has not decreased by >=30% by day 4. Variceal bleeding: 2 mg IV initially, then 1-2 mg every 4-6 hours for up to 48 hours., administered via Intravenous bolus injection, Every 6 hours.

Complete dosing reference for Terlipressin (Reproductive / Hormonal). Covers reconstitution, dose range, titration schedule, pharmacokinetics, and storage protocols for research use.

Dosing Protocol

Route: Intravenous bolus injection Frequency: Every 6 hours Dose Range: HRS-1: 0.85 mg IV every 6 hours; may increase to 1.7 mg every 6 hours if serum creatinine has not decreased by >=30% by day 4. Variceal bleeding: 2 mg IV initially, then 1-2 mg every 4-6 hours for up to 48 hours.

Timeline & Pharmacokinetics

Onset: 15-30 minutes (IV) Half-Life: ~50 minutes (terlipressin); ~6 hours (active lysine-vasopressin) Washout: 12-24 hours

Storage

Lyophilized: Store at 20-25 °C (68-77 °F) Reconstituted: Use immediately after reconstitution; do not store reconstituted solution

Safety & Contraindications

Safety: Respiratory failure: observed in 11% of terlipressin-treated patients vs 2% placebo in CONFIRM trial; FDA boxed warning for serious or fatal respiratory failure Abdominal pain and diarrhea (common) Peripheral ischemia: digital ischemia, skin necrosis, and intestinal ischemia reported

Contraindications: Hypoxia or worsening respiratory symptoms (FDA boxed warning); Patients with ongoing coronary, peripheral, or mesenteric ischemia; Hypersensitivity to terlipressin or vasopressin analogs

Peptide Tools

Reconstitution CalculatorCalculate concentration and syringe units for any peptide vial with visual syringe guide.

Dosage & Cycle PlannerPlan a multi-week peptide cycle. Calculate total supply needed and vial counts.

Bacteriostatic Water CalculatorCalculate how many vials of bacteriostatic water you need for your peptide stack.

Cost-Per-Milligram CalculatorCompare vendors side-by-side. Find the best value per milligram and per dose.

Frequently Asked Questions

Related Resources

Browse All Research Peptides

Explore More

Terlipressin Dosing Guide Peptides for Reproductive Health Peptides for Critical Care

Research Use Only. The information on this page is compiled from published research literature and is provided for educational purposes only. It does not constitute medical advice. All compounds referenced are intended for in vitro research use by qualified laboratories and institutions.